Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

By Davidkin I.   Valle M.   Julkunen I.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1617-1622

Elsevier

Access to resources Recommend Favorite

Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme

By Broliden K.   Abreu E.R.   Arneborn M.   Bottiger M.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 323-327

Elsevier

Access to resources Recommend Favorite

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

By Miller E.   Rush M.   Hill A.   Morgan-Capner P.   Forsey T.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G.   Gay N.J.   Hesketh L.M.   Vyse A.   Morgan-Capner P.   Brown D.W.   Litton P.   Miller E.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite